higher dose of semaglutide The obesity treatment landscape continues to evolve. A higher-dose version (Wegovy 7.2 mg) has recently been studied and approved, based on large clinical trials showing additional weight loss compared to High weekly s.c. semaglutide dose
Description
In the trial that got Zepbound approved, the average person on the highest 15 mg dose lost 20.9% of their body weight over 72 weeks
Last Updated: 06-25-2026
GLP-1 convert
Understanding your biomarker profile and genetic predispositions can support more informed conversations with your provider about optimal dosing
If your law firm is taking up GLP-1 drug cases, Atraxia Media can efficiently help you find the most suitable clients
GLP-1 usage has reached double digit penetration in the UK and Germany
